These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 18308783)
1. Psychopharmacology of pediatric obsessive-compulsive disorder: three case reports. Oner O; Oner P J Psychopharmacol; 2008 Sep; 22(7):809-11. PubMed ID: 18308783 [TBL] [Abstract][Full Text] [Related]
2. Risperidone and haloperidol augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder: a crossover study. Li X; May RS; Tolbert LC; Jackson WT; Flournoy JM; Baxter LR J Clin Psychiatry; 2005 Jun; 66(6):736-43. PubMed ID: 15960567 [TBL] [Abstract][Full Text] [Related]
3. Obsessive-compulsive disorder presenting with gender incongruence obsessions. Uvais NA; Sreeraj VS Asian J Psychiatr; 2017 Dec; 30():77-78. PubMed ID: 28837942 [No Abstract] [Full Text] [Related]
4. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953 [TBL] [Abstract][Full Text] [Related]
5. The comparison of aripiprazole and risperidone augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder: a single-blind, randomised study. Selvi Y; Atli A; Aydin A; Besiroglu L; Ozdemir P; Ozdemir O Hum Psychopharmacol; 2011 Jan; 26(1):51-7. PubMed ID: 21308781 [TBL] [Abstract][Full Text] [Related]
6. [Effectiveness and tolerability of addition of risperidone in obsessive-compulsive disorder with poor response to serotonin reuptake inhibitors]. Arias Horcajadas F; Soto JA; García-Cantalapiedra MJ; Rodríguez Calvin JL; Morales J; Salgado M Actas Esp Psiquiatr; 2006; 34(3):147-52. PubMed ID: 16736387 [TBL] [Abstract][Full Text] [Related]
7. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. McDougle CJ; Epperson CN; Pelton GH; Wasylink S; Price LH Arch Gen Psychiatry; 2000 Aug; 57(8):794-801. PubMed ID: 10920469 [TBL] [Abstract][Full Text] [Related]
8. Effects of selective serotonin reuptake inhibitors on thought-action fusion, metacognitions, and thought suppression in obsessive-compulsive disorder. Besiroglu L; Çetinkaya N; Selvi Y; Atli A Compr Psychiatry; 2011; 52(5):556-61. PubMed ID: 21109243 [TBL] [Abstract][Full Text] [Related]
9. Granisetron-mediated augmentation of sertraline therapeutic effect in obsessive-compulsive disorder: a double-blind placebo-controlled, randomized clinical trial. Ghobadian A; Mokhtari S; Shariati B; Kamalzadeh L; Shati M; Eftekhar Ardebili M; Yarahmadi M; Shalbafan M BMC Pharmacol Toxicol; 2022 Sep; 23(1):73. PubMed ID: 36167636 [TBL] [Abstract][Full Text] [Related]
10. Obsessive compulsive disorder in huntington disease: a case of isolated obsessions successfully treated with sertraline. Patzold T; Brüne M Neuropsychiatry Neuropsychol Behav Neurol; 2002 Sep; 15(3):216-9. PubMed ID: 12218715 [TBL] [Abstract][Full Text] [Related]
11. Antiobsessional effect of risperidone add-on treatment in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder may be dose-dependent. Ramasubbu R Arch Gen Psychiatry; 2002 May; 59(5):472; author reply 472-3. PubMed ID: 11982460 [No Abstract] [Full Text] [Related]
12. Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders. Stein DJ; Bouwer C; Hawkridge S; Emsley RA J Clin Psychiatry; 1997 Mar; 58(3):119-22. PubMed ID: 9108814 [TBL] [Abstract][Full Text] [Related]
13. Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder. March JS; Franklin ME; Leonard H; Garcia A; Moore P; Freeman J; Foa E Biol Psychiatry; 2007 Feb; 61(3):344-7. PubMed ID: 17241830 [TBL] [Abstract][Full Text] [Related]